Abstract
B-PROPIOLACTONE has been reported1–4 to be a potent but slowly acting carcinogen in vivo. In an investigation of the effects of this agent on rat fibrocytes cultivated in vitro, treated cells were found to undergo a particular sequence of structural alterations which culminated in cytological malignancy. This sequence of changes appeared to be directly related to the process of carcinogenesis.
Similar content being viewed by others
References
Walpole, A. L., Roberts, D. C., Ross, F. L., Hendry, J. A., and Homer, R. F., Brit. J. Pharmacol. Chemother., 9, 306 (1954).
Roe, F. J. C., and Glendenning, O. M., Brit. J. Cancer, 10, 357 (1956).
Dickens, F., and Jones, H. E. H., Brit. J. Cancer, 15, 85 (1961).
Dickens, F., Cancer and Hormones, 107 (Chicago Univ. Press, 1962).
Brachet, J., Biochemical Cytology (Academic Press, New York, 1957).
Waddington, C. H., New Patterns in Genetics and Development (Columbia Univ. Press, 1962).
Bernhard, W., Exp. Cell. Res., Suppl., 6, 17 (1958).
DeRobertis, E., Nat. Cancer Inst. Mono., 14, 33 (1964).
Estable, C., and Sotelo, J. R., Fine Structure of Cells. Eighth Congr. Cell Biology, Leiden, Union Intern. Sci. Biol. Ser. B., 21, 170 (1954).
Perry, R. P., Nat. Cancer Inst. Mono., 14, 73 (1964).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
POWELL, A. Effects of Propiolactone on Rat Fibrocytes. Nature 209, 77–78 (1966). https://doi.org/10.1038/209077a0
Issue Date:
DOI: https://doi.org/10.1038/209077a0
- Springer Nature Limited